TP53 and cancer: We noticed that CESC was an exceptional cancer type that has higher immune score; however, it did not show higher expression of genes in the IFN α/γ pathway or chemokine signaling pathway in p53-wt patients as compared to p53-mut patients (Figure 6B compared to Figure 6D).